Professional Documents
Culture Documents
Vol. 52, No. 48, pp. 15031-15070, 1996 Copyright 0 1996 Elsevier Science Ltd Printed in Great Britain. All rights reserved 0040.4020/96 $15.00 + 0.00
TETRAHEDRON
REPORT NUMBER
410
Contents
Introduction 1a. Scope of this review lb. Tetrahydroquinolines lc. Other applications 2. From Unsaturated as natural and pharmaceutical of tetrahydroquinolines Ring products 15032 15032 15032 15033 15034 15034 via 15036 15039 15041 15041 I5043 15045 15047 15048 system 15051 15053 from Aniline Imines 15054 I5055 15056 Fragment 15057 15058 15059 15031
to Saturated Heterocyclic
ring in quinolines
of quinolines to 1,2,3,4-tetrahydroquinolines
5b. Other groups X in the ARNCH,X 5c. Oxidation of N-methylanilines 6. Preparation of 2-Substituted
Tetrahydroquinolines
6a. Reactions of Schiff bases 6b. Aniline alkylimines I. 8. 9. Preparation by Insertion of a C(2)-C(3) Ring Contraction Summary and Ring Expansion
15032
A. R. KATRITZKY et al.
1. Introduction
la. Scope of this Review Rapid recent developments and classify all their major in the chemistry of 1,2,3,4-tetrahydroquinolines synthetic methods currently in use. has prompted this report 2-0x0-, us to review to 1,2,3,4-
We restrict
tetrahydroquinolines
in which the C-2, C-3, and C-4 atoms are all sp hyhridized. (classiiied as such by Chemical Abstracts)
dioxo-1,2,3,4-tetrahydroquinolines
or more sp* carbon atoms form a large group of quinoline derivatives distinct synthetic methods: they are considered
of saturated
tetrahydroquinolines.
This review is intended to cover the literature of the last ten years,
1986-95.
lb. Tetrahydroquinolines
Products is due to their biological activities. Several of these is present in human brain.
2-Methyl- 1,2,X4-tetrahydroquinoline
antitumor untihiotic, has a complex structure built on the tetrahydroquinoline tetrahydroquinoline 1, isolated from Martinella iquitosensis, and muscarinic receptors.
synthetic of 1,2,3,4-tetrahydroquinolines
tested as
and virantmycin (4) a novel antihioticz2*24 are the best known. Tetrahydroquinoline the most potent NMDA antagonists yet found.z5-2
2, oxamniquine
iI
3, nicainoprol
kNJJ
Synthesis of I ,2,3,4-tetrahydroquinolines
15033
4, viratmycin
5, L-689,560
Hundreds biochemial
of tetrahydroquinolines
bearing
various
simple
or complex
substituents
have
interesting 2-methyl-S1,2,3,4are I
pharmaceutical
exhibits analgestic
enzyme,7
leukotriene
synthesis4142 and
and
ca1cium,46 nervous
system depressants,
positive
antiarrhytmic,s7
antiaIlergenic,5R
antitumor,
receptor,
of noradrenergic
or
pharmaceutical
76-70
1,2,X4-tetrahydroquinoline
in various types of dyes: for hair,x2 for acrylic tibers,Rs4 for polyesters,x5.w and for polyamides.x7~xx (28)-2,6Dimethyl-1,2,3,4-tetrahydroquinoline properties. Tetrahydroquinoline transporting sensitive derivatives are also widely used in modern photoconductors,n recording technologies: as chargewas used in synthesis of china1 polymethine dyes with interesting optical
as tuco
materials,7-0 recording
information
as intermediates
electrostatographic
in photography.s
15034
A. R. KATRITZKY et al.
2. From Unsaturated
&spite
the recent availability of many alternations direct reduction Hydrogenation of the heterocyclic
quinolines
are of
easily accessible,
over platinum is a common approach, 4R.lW-z which gives high yields of substituents (6a) and on the heterocyclic ring, as is illustrated (fib)
quinoline-2-carhaldehydeLL4
to
tetrahydroquinolines
Hydrogenation
of quinaldinic
methanol proceeds well under very mild conditions, at room temperature and under atmospheric
Electron-donor
(conversion
of Sa to 9aX5 of 8b to
and 10 to 1147), whereas even a methyl group at C-4 retards the reaction dramatically 9b3).
(conversion
# = CH*OH R2 = C&OH
(90%) (27%)
NHCHO
10
11(69%)
Other metal catalysts can also he used in the hydrogenation Thus, cobalt stearate in the presence of triethylaluminum
converts
(13) quite well.6 The use of rhodium complexes agent were considered
as a breakthroughs:
to tetrahydroquinolines
Synthesis of 1,2,3,4-tetrahydroquinolines
15035
12
13 (76%)
To avoid pressure reactors, hydrogen transfer can be utilized. Thus, quinoline 12 is reduced efficiently to tetrahydroquinohne Nickel-aluminum 13 by mixing formic acid and triethylamine in the presence of a palladium catalyst. acids, as shown hy the
alloy is a convenient
conversion of 16a, 16b, and 16c to 17a, 17b, and 17c, respectively.
COOH
13 (85%)
Alcohol-sodium
systems
in causing
reduction
of the
k/J
18
f-
Na, n-BuOH w H 19
f-0 Nd
+ 20
r-0 Nd
(50%, isolated)
when borohydrides
of 12 to 13.
Me
Me
15036
A. R.
&UFUTZKY
et al.
As shown above, reduction of the heterocyclic of 1,2,3,4-tetrahydroquinolines. their synthesis may outweigh used, e.g., conversion heterocyclic
However, when the starting quinolines have to be prepared, the complexity of the simplicity of the reduction step. Although such approaches are still widely of the saturated can
of aniline 21 to tetrahydroquinoline
ring of 1,2,3,4-tetrahydroquinolines
Cl POW*
(98%) (94%)
nucleophiles which
converted
subsequent
2-suhstituted
Thus, the reaction of quinoline with hutyllithium gives dihydroquinoline (25) in excellent yield.42.4 Reaction
to 2-hutyl-1,2,3,4-tetrahydroquinoline
ethylmagnesium
gives dihydroquinoline
to tetrahydroquinoline nucleophiles,
27.12 Q ua t ernization of the nitrogen atom of yuinoline allows the attack of even weaker
24 (97%)
25 (96%)
Synthesis
of 1,2,3,4-tetrahydroquinolines
15037
:I 0
\
/
Et &Me 27 (92%) CHCl3 /NaOH CCI, tie 28 (66%) 29 (6%) H2, Pd/C * CCI,
In some instances, the addition does not stop on 1,2-dihydroquinolines, the heterocyclic organohoron ring becomes saturated. Reactions with an organosilicon
reagents
A
32 (40%)
Reduction tetrahydroquinolines.
is not
the
only
method
for
the conversion
of
1.2-dihydroquinolines
into
1,2,3,4-
The C(3)-C(4)
bond of 1,2-dihydroquinolines
of an electron
rich double bond which allows a wide range of addition reactions. Thus, hromination 34.12 Formation assigned. of dihydroquinoline
1,2,3,4-tetrahydroquinoline
the stereochemistry dihydroquinoline was not 35 into
In another
hromination
in water
converts
dihydroquinoline of
preparation
highly
33
35 34 (60%)
36 (99%)
15038
A. R. KATRITZKY et al.
m-CPBA
, / b 37
NOz
\ , b
40 derivative 41, which
N4
38 (70%)
Sodium
cyanohorohydride 39) to
reduces give
3,4-dichlorotetrahydroquinoline
(obtained the
of a
dihydroquinoline tetrahydrnquinoline
monochloro
illustrates
suhstituent at C-4.24
to tetrahydro to quinolines.
with dimethylpropargy?
propargyl derivative 42, which in the presence of a cuprous chloride catalyst is converted 43. Conversion of the aniline derivative 44 to dihydroquinoline
Me0
42
HCSCOMe
Synthesis
of 1,2,3,4-tetrahydroquinolines
15039
A further method involves reactions of anilines with a&unsaturated an example, condensation gives aminoalcohol of N-methylaniline with cinnamaldehyde
carhonyl compounds.
As
dichloride
46
47 (57%)
2c. Derivatization
of 1,2,3,4-Tetrahydroquinolines and its simple alkyl derivatives can be used as sources for of 1,2,3,4-tetrahydroquinolines at C-2 is
oxidation by hydrogen peroxide in the presence of sodium tungstate.34 hydroxamic acids 4Sa and 48b from 1,2,3,4-tetrahydroquincline hydroxamic acids thus ohtained can he easily
converted
2-axo- 1,2,3,4-
tetrahydroquinolines
hy hydrogenation R
-ti
:I
N bH
R = H (84%) R = Me (83%)
methods
lithiation developed.
hy
electrophiles
tetrahydroquinoline
is first converted
to a formamidine
derivatives plays hoth the rule, of an activating and a directing group. electrophiles gives 2-suhstituted 1-formamidinotetrahydroqumolines.
Lithiation of 4Y and
treatment
is removed
in a reaction with hydrazine to give tetrahydroquinoline milder reaction conditions preparation of compound (no need fur turf-hutyllithium), 51.tq7- 14
13.? Use of
Me A
Me
15040
A. R.
KATFUTZKY
et al.
* Cp&?!rMeCI A
BuLi
PrcECPA
q+
51 (85%)
is converted
derivative
52 by
treatment with hutyllithium and carbon dioxide. In the following step, carhamate 52 is lithiated by with tert-butyllithium, and finally subjected to a reactions with clectrophiles to give suhstituted giving, e.g.,
at the 2-position
1) BuLi
iiT J$ %
kO,Li 52
A 53a (55%)
A 53b
Biochemical on
~_4.42,14
oxidation of tetrahydroquinolines
Conversions
biochemical derivatization
oxidation. Contrary to the ahove methods, a reaction with elemental sulfur allows for simultaneous at C-l and C-4; thus, converting tetrahydroquinoline 60 into the tricyclic dihydroquinoline
derivative 61.44
Cunninghamella elegans )
OH
0 +
ti
:I
PhAO 56
Cunninghamella elegans b
Me
Me
Me
.Me
OH
59
Synthesis
of 1,2,3,4-tetrahydroquinolines
15041
Me
S
MeA Me
Me
ti
:I
A
60
Me
03
:I
k
61 (47%)
s, S
Me Me
desired substitution
of the heterocyclic
ring in tetrahydroquinolines,
this ring from smaller fragments than from the corresponding in many ways.
can he constructed
3a. Formation of the N-(Cl) Bond In general, N-C bond formation ortho-substituted is one of the simpler tasks in organic synthesi to the corresponding and, if appropriately is easy.
1,2,X4-tetrahydroquinolines
makes them attractive starting materials for the preparation of 2(62) is converted to 2-(4acid.14
(63) in a cyclization process catalyzed by phosphoric to reduction and addition reactions providing
additionally substituted
62
63 (65%)
0
Br,
Br Ph NaOH MeOH
Me0
OMe
AC 64
AC 65
AC 66 (25%)
15042
A. R. KATRITZKY et al.
ortha
of the toluidine derivative 67 with NBS followed by condensation 68, which is then cyclized reduction to 2-oxotetrdhydroquinoline
69 upon treatment
in ethanol.47 Subsequent
giving 3-aminotetrahydroquinoline Me
70 in good yield.47
COOEt
_)
In another example, the 3C linkage (in 72) is constructed with 71. In the next step, catalytic reduction
onto 2-nitrohenzaldehyde
followed hy cyclization to give derivative 73.4R When the hydrogenation and atmospheric temperature pressure, compound 73 can he isolated
and 40 atm of H,, the reaction does not stop on 73, which is then decarboxylated 74.14
EtO,C +
NO2
and reduced to
tetrahydroquinoline
CHO
Ph,P=HC 71
) toluene
THF
_
ortho
HP, P&C
nitro group is added later, after the 3C linkage unit is already constructed, 76 is prepared hy nitration of 75 under mild conditions. from the amino group to
of 76 reduces the nitro group and then removes protection 77. Methylation
of the amino group at C-3 gives 78, which is con.secuGvely (23), a precursor of positive
6,7-dimethoxy-3-(dimethylamino)-l,2,3,4-tetrahydroquio~e
inotropic agents. This synthesis of 23 can he compared with the alternative approach, which proceeds through quinoline system 22.
Synthesis
of 1,2,3,4-tetrahydroquinolines
15043
75
76 (76%)
77 (91%)
76 (90%)
23 (28%)
The 3C linkage can he added in one step hy palladium catalywd iodoanilines. 4Y For example, the palladium intermediate 79, obtained
annulation
hy treatment
palladium acetate,
to give 2-vinyl-1,2,3,4-tetrahydroquinoline
via 80 and
81. 4y
60
of N-alkylidene~nilines
with allylmagnesium
undergoes sulfuric acid catalyzed cyclization to a mixture of cis (85) and trms tetrahydroquinolines.O In the second example, a mixture of tetrahydroquinolines 88, ohtained from N-cyclohexylidene-3methylaniline
4-methyl-2-phenyl-
cyclization of intermediate
CH2=CHC&MgBr @Ph
63 A 64 (78%)
I
predommant \
i6.
. .
&
minor ,
50%
15044
A. R. KATRITZKY et al.
Me
:I b8
87
Cb=CHCWp
&A%
99
q
. 99
+&%
90 , I:1 mixture
is well
illustrated
by the synthesis
of tetrahydroquinoline
in the
of antiulcer agents.51 In the first step, the hydroxy and the amino group in 2-(hydroxymethyl)as benzoxazine 91 by reaction with trichloromethyl chloroformate. The N-H lmnd of 91
92 in high yield. Hydrolysis of the ester function gives acid 93, acid to form 4-oxotetrahydroquinoline
91
(74%)
92
(90%)
93 (92%)
94 (60%)
95 (79%)
96 (94%)
97 (64%)
of the carbonyl group of 94 followed by methylation 97, via intermediates 95 and 96.
and deprotection
Use of aldehydes or their derivatives in the cyclization step instead of carboxylic acids allows simplification of the procedure hy obviating reduction of the carbonyl group. Soft nucleophiles present in the
of both these ideas was utilized in the work presented below. Thus, the derivative 98,
Synthesis of 1,2,3,4-tetrahydroquinolines
15045
reaction
4. Condensations
one century,
anilines
react
However, until
the X-ray
4-hydroxy-1,2,3,4-tetrahydroquinolines became
to a recent
p-toluidine
of acetaldehyde
gives a mixture of the cis (101) and truns (102) in an approximate ratio of 1:2. The isomers by NMR methods.s and
was assigned
Under a different set of reaction conditions glycolaldehyde crystallography give tetrahydroquinoline data.15
(1:l molar ratio and lack of acidic catalysis), N-methylaniline 103, the stereochemistry of which was assigned
based on X-ray
HCI-Hz0
L2MeCHo
2 tile
+ 2 HOW&HO
the 103 (45%) to product 103 is substitution of the 4-hydroxy group in the
mechanism
leading
4-hydroxytetrahydroquinobne
by excess N-methylaniline;
cannot be
excluded. Thus, formation of a simiiar product, tetrahydroquinoline first, condensation of aniline with acetaldehyde
H+h
h
TiCh, k 104 105 (34%) Me
15046
A. R.
KATRITZKY
et al.
The detailed
mechanism
of such reactions
Thus, condensation
of N-
methylaniium propionaldehyde
perchlorate
to 106 produces
refluxing in chloroform
10s is unstable
109 and then oxidation to quinolinium salt 110. Other aldehydes, unhranched producing homologs of 110with yields in the range of S-30%~.sx
Me
108
109
110 (45%)
According tetrahydroquinoline
to our own
findings,
addition
of benzotriazole
to the reaction
mixture
stabilizes
the
system by suhstitution
2 PhCH&HO benzotriazole *
\ R \,
N NN
an almost
NXH
the
p-TsOH
+
Me Ph 112 mixture of stereoisomers(lOO%)
* Me Ph
PhMgBr
LiAIHl
113 (90%)
Me Ph 114 (39%)
115 (78%)
111 and 112 is achieved, from which the predominant moiety on C-4 of tetrahydroquinoline 114 can be
isomer
The benzotriazolyl
Synthesis of 1,2,3,4-tetrahydroquinolines
15047
hy strong nucleophiles,
113 and
Mixtures of isomers 116 obtained from reactions of N-methylaniline difficult to separate. (117a and llSa, However, the corresponding
pairs of diastereomeric
after reduction
a; Lie R
q Lie R
117a, R = Me (45%)
117b, R = Pr (55%)
118a, R = Me (35%)
IlSb, R = Pr (33%)
4-ethoxy-2-methyl-1,2,3,4-tctrahydroquinnoline
of these reagents.
EtOH I TQ
350nm
NO2 * Me-Me + ON&
H 119 (71%)
minor
This unsuhstituted
approach
allows
the
preparation
of
various
3,4-disuhstituted
at C-2. The concept is to generate from an aniline derivative 120 a methyleneiminium attack on an oletii leads to an intermediate cation 122 and spontaneous rule, regioselectivity
cyclization to is achieved
N
Al 120
pH2
RI x121
R&H=CHR3
aFR2
dR2
Al 122
Al 123
15048
A. R. KATRI'IZKY
etal.
5a. Benmtriazole Methodology The benzotriazolyl these reactions: substituent Bt (benzotriazol-l-y1 and/or -2-yl) is very advantageous and characterized, as group X in but also reactive
it renders derivatives
species 120 and 121 coexist at equilihrium in derivative 125 (obtained readily hy
In two
diphenylamine
of diphenylamine
with formaldehyde
and knzotriazob)
even better when olefms are activated by a heteroatom63 Thus, N-methylaniline adduct 128 stabilized by the ethoxy group,
129. Compound
the ethoxy
be used as a starting
rlr e
127
RMgX toluene
:I co
R
the
compound
Synthesis of 1,2,3,4-tetrahydroquinolines
15049
can be separated
from the reaction mixture by fractional distillation (in 61% yield); however,
treatment
with
lithium aluminum hydride in refluxing an&sole converts reaction of 127 with 3,4-dihydro-2H-pyran tetrahydroquinoline (137), via intermediates proceeds
134. The
rib
132
tile 136
Reactions
of N-[(benzotriazol-
1-yl)methyl]anilines
aldehydes
proceeds
similarly to intermediates
139, cannot be isolated, as the hydroxy group undergoes rapid substitution with knzotriazole 130 and 142. Iminium cation 140 is implicated as a key intermediate 142, and also in subsequent conversions in which the benzotriazolyl starting for the preparation
of compounds
are convenient
in preparation
as demonstrated
130 to tetrahydroquinolines
of 142 to tetrahydroquinolines
N-Bt Al 136
15050
A. R.
KATRITZKY
et al.
Reactions benzotriazol-l-y1
produce
mixtures
of diastcreomers
and 2-yl isomers. These complex mixtures, are converted into single products
without purification.
aluminum hydride,
with phenyhnagnesium
146a and 146b. This is the best method currently available for the ring.4
Bt Rl
Me J
Ph
he
4-(Dialkylamino)tetrahydroquinohnes methodology.
can
be
also
conveniently
prepared
using
benzotriazole give 4-
(2-pyrrolidinon-l-yl)tetrahydroquinolines
of the curbonyl group with lithium 148. N-Vinylacetamide 150.This method allows groups, for
aluminum hydride converts these products into 4-(pyrrolidin-1-yl)tetrahydroquinolines reacts similarly, as it is shown in preparation also for convenient syntheses of julohdines of 151from 14Y, via amide intermediate suhstituted at C-l
l-3 N
LiAIH, *
:I 05
N
I4
136
Synthesis
of 1,2,3,4-tetrahydroquinolines
15051
X in the ARNCHaX
System
alkenes.
iv thus
with fornu~ldehyde
and a styrene
in the presence
R Ph
NH2
Me
CF,CO,H
153
Other
methods
of the methytne
iminium
cations
121 involve
ionization and of
of NN-
triphenylhexahydro(alkoxymethyl)anilines
(155), prepared
hy condensation
(157), prepared
by electrochemical~
in the preparation
15052
A. R. KATRllZKY
et al.
and thiophenol 74
seem
of tetrahydroquinolincs, (MO),
(161) catalywl
160 (87%)
147b (75%)
161 (67%)
prepared hy condensation
reagents. 76 Thus, two examples of reactions of cc-arylaminomethyl tetrahydroquinolines 131~ and 164, respectively,
to give
illustrate
Arylaminomethylnitriles
131~.~
NH
he
162 (92%)
131~ (72%)
Synthesis
of 1,2,3,4-tetrahydroquinolines
15053
Me
163 (87%)
164 (92%) Ph
5c. Oxidation of N-Methylanilines Oxidation of N-methylanilines N-methylaniline hydroperoxide. 7x producing (166) is prepared can give N-arylmethyleneiminium conveniently of Lewis cations. Thus, N-(t-hutylperoxymethyl)in a reaction with terr-hutyl anion of
In the presence
N-methyl-N-phenylmethyleneiminium
cation.
tetrahydroquinolines
&fins
167 (77%)
166 (71%)
169 (41%)
unsuhstituted of derivative
hy this method
using A -silyl
171.17 Titanium
15054
A. R. KATRrIZKY
et al.
f-EuOOH -
CH,=CHCH,SiMe, rnCOCMea
Sit&&Me3 171 (63%) H 158 (64%)
RuCI,(PPhs)s Sitvle,@le,
170
N-(Arylamino)-N-methylmethyleneiminium N,N-dimethylanilines
cations can he directly ohserved hy NMR during oxidation of The cations can he trapped hy olefms of N,N-dimethylaniline with oxygen to
with nitric oxide in the presence of Lewis acids. e.g., 172. Iron salts catalyze oxidation
cations, which are efficiently trapped hy vinyl ethers to give 4-alkoxytetrahydroquinolines Reaction of aniline N-oxides with olefms in the presence of an iron(II1) C&capped porphyrin (174). hut the mechanism involved i klieved to have radical
NO ,,,,Me
tie
BF,
M%C=CMe, ) I
tie 0 ,Bu-n tie 172
be 173
N + kr%e 0 Me
Me Me Me
Mve
6. Preparation
of 2-Substituted
Tetrabydroquinolines
Condensations tetrahydroqumolines
of an enolizahle
aldehyde
RCHzCHO
give 1,2,X4-
hoth an RCHZ group on C-2 and an R group on C-3. In instances where it is hut not C-3, direct derivatization of tetrahydroquinolines discussed earlier may
Synthesis
of 1,2,3,4-tetrahydroquinolines
15055
of Schiff Bases substituents unsaturated on C-2, amines the Schiff bases can be treated with allyhnagnesium cyclized to tetrahydroquinolines under reagents and the The
obtained
acidic catalysis.
of phenyliminomethylpyridines
175 to 4-methyl-2-pyridyl-1,2,3,4-tetrahydroquinolines
(177), via
amines 176,t5 illustrates this approach. Some additional examples of such reactions are given earlier (83%).
175
k 177
with Lewis acids activates the a carbon to ekctrophilic with olefms. Comparison
of the yields of 17Ya-c.X shows that electronThe milder yterhium Lewis of 180 to
acid catalyst works well even with electron-donating 181a and 181b;4 the ratio given in parentheses
corresponds
products.
PhCH=CH* N+Ph 178 178a, R = NO, (99%) 179b, R = CN (80%) 179q R = H (39%) FeC$ Ph
@Ph 180
Yb(OTFh
of mixtures
of Schiff
hase
with
DDQ
produces
2,4-disuhstituted
tetrabydroquinolines
15056
A. R. KATRITZKY et al.
182 \ n-BuOCH=CH2
183 (20%)
184 (51%)
185 (16%)
Often, the whole process
188 (5%)
can be accomplished
of the intermediate
Schti
of tetrahydroquinolines
is provided.
S
,f=h
6b. Aniline Alkylimines In place of aromatic synthesis of antagonists rings, alkoxycarbonyl groups can stabilize the intermediate imines. Thus, in a 190z5 and 1926 are
for the glycine site of the NMDA receptors, esters 189 and 191, respectively.
tetrahydroyuinolines
Synthesis
of 1,2,3,4-tetrahydroquinolines
1.5057
+
cl 191 @CO,Me
0-Ph
COfie
The stahizing influence of an electron-withdrawing -methoxyalkyl)anilines trifluoroethyl)anilines 194a and 194b hy electrophilic
trifluoromethyl
of N-(a N-(2,2,2-
anodic oxidation
193. In the presence of titanium tetrachloride, intermediates 194a and 194b react with as
trtms
isomers.
suhstituents
with isohutyraldehyde to
I-vinyl-2-pyrrolidinone
tetrahydroquinoline
197, predominantly
2e
CFs R 194a, R = Et l94b, R = Ph 195a, R = Et (63%) 195b, R = Ph (63%)
MeOH
cHM~
he
tile
196 Bt = benzotriazol-1 -yl or -2-yl
7. Preparation
Although
less common,
reactions
of nrtho-methyleneiminoquinones patterns
of 1,2,3,4-tetrahydroquinolines
15058
A. R. KATRITZKY
et al.
(198) eliminates sulfur dioxide upon heating to produce ortho-methyleneiminoquinone dienophiles to give 2,3-disuhstituted-1,2,3,4-tetrahydroquinolines, azido-1-methylindole
1 -A.+
c ---L
,_,,
Brdiethyl fumarate L
204
205
205 (85%)
8. Ring Contraction
Chlorinations
of the corresponding
pentaehloride, to form
give Schloro
2-amino-1,2,3,4-
in high yields.* As an example, Sphenyl derivative 208 upon heating with piperidine at retlux for 2 hours.
tetrahydroquinolines
Synthesis
of 1,2,3,4-tetrahydroquinolines
15059
methylindane
(209)
upon
treatment
with
lithium
aluminum
hydride.
The
opposite
conversion, of
from
tetrahydroquinolines
in preparation
fungicide 211
from tetrahydroquinoline
Me Me--t-\
HP04
9. Summary
2-monosuhstituted
(i) from quinolines hy reduction (ii) from dihydroquinolines (iii) from tetrahydroquinolines by substitution (i) from quinolines hy reduction (ii) using henzotriazole methodology (i) from quinolines by reduction (ii) using henzotriaole methodology (iii) other ArNCH2 methodology (i) from aniline with two moles of RCHO (ii) from ortho methyleneiminoquinolines (i) from Schiff bases using benzotriazole methodology
3-monosubstituted
4-monosuhstituted
2,3-disubstituted
sa
2h 4 6a
(i) from dihydrcquinolines (ii) from anilines and two moles of RCHO (iii) from Schiff bases
15060
A. R. &+SRllZKY et ai.
Many good synthetic methods for 1,2,3,4-tetrahydroquinolines ring have been recently developed. parameters Table. to consider
bearing substituents
The nature, number and relative location of the substituents a method. Recommended the best synthetic for methods making
Benzotriazole
is frequently
method Suhstitution
monosuhstituted
and 3,4-disuhstituted
tetrahydroquinolines.
at the nitrogen
and at the
aromatic ring, not considered in this review, may also influence the choice of the optimum method.
Y.; Nagatsu,
T. Biochem.
10X4-1089.
2. 3. 4. s. 6. 7. X. 9. 10.
Perry, N. B.; Blunt, J. W.; McComhs, J. D.; Munro, M. H. G. J. Org. Chrm. 1986. 51. ~54765478. Perry, N. B.; Blunt, J. W.; Munro, M. H. G. TetrrLhrdron 1988,44, 1727-1734.
Perry, N. B.; Blunt, J. W.; Munro, M. H. G.; Higa, T.. Sakai, R. J. Org. Chrm. 1988, .53,4127-412X. Nishiyama, S.; Cheng, J.-F.; Tao, X. L.; Yamamura, S. Tetruhrdron Left. 1991,32,4151-4154. Kita, Y.; Tohma, H.; Inagaki, M.; Hatanaka, K.; Yakura, T. J. Am. Chrm. Sot. 1992. 114.217.5-2180. White, J. D.; Yager, K. M.; Yakura, T. 1. Am. Chrm. Sot. lYY4, 116, 1X31-1X3X. Konishi, M.; Ohkuma, H.; Tsuno, T.; Oki, T. J. Am. Chrm. Sot. lYy0, 112, 3715-3716. Wender, P. A.; Zercher, C. K.; Beckham, S.; Hauhold, E.-M. J. Org. Chem. lYY3,5X, 5X67-5869. Witherup, K. M.; Ransom, R. W.; Varga, S. L.; Pitzenbqcr, Pat. US .5,2X8,725, 1994; Chrm. Ahstr. 1994, 121, 91779s. S. M.; Lotti, V. J.; Lumma, W. J. U.S.
Kokwaro, G. 0.; Taylor, G. Drug Chem. Toxicnl. 1990, 13, 347-3.54. Wong, L.-J. C.; Tsao, G.-C.; Bruce, J. I.; Wang, S. S. Exptv?entia lYYo,46,461-464. El Ragehy, N. A.; El Tarras, M. F.; Khattah, F. I.; Ahmad, A. K. S. Spuctmsc. Lett. lY91, 24, X1-97. El Tahir, K. E. H.; Al-Kharji, A. M. H.; Ageel, A. M. Cm. Pharmnc. 1992. 23, 131-139. Prankerd, R. J.; Ahmed, S. M. J. Pharm. Pharmacol. 1992,44, Prankerd R. J.; Ahmed, S. M. J. Pharm. Pharmocnl. 19Y2,44, 259-261. 26 I-263
Kimura, T.; Imanishi, S.; Arita, M. J. Currliovtwc. Phnrmucol. lY8Y, 13, 767-773. Hashimoto. K.; Akiyama, K.; Mitsuhashi, H. Jpn. J. Pharmwol. lY8Y, 4Y, 24.5-254.
Synthesis
of 1,2,3,4-tetrahydroquinolines
15061
Weirich,
Weirich, J.; Antoni, H. 1. Curdiovusc. Pharmacol. 1990, 15,998- 1009 Omura, S.; Nakagawa, A. Tetruhedron Lett. 1981,22,2199-2202. Francis, C. L.; Ward, A. D. Aust. J. Chem 1994,47, Williamson, 2109-2117.
N. M.; March, D. R.; Ward, A. D. Tetrahedron Lrtt. 1995, 36, 7721-7724. G.; Chan, T.;
Leeson, P. D.; Carling, R. W.; Moore, K. W.; Moseley, A. M.; Smith, J. D.; Stevenson, Baker, R.; Foster, A. C.; Grimwood, 1992,35, 1954-1968. S.; Kemp, J. A.; Marshall, G. R.; Hoogsteen,
K. J. Mud. Chem
26.
Pangalos, M. N.; Francis, P. T.; Foster, A. C.; Pearson, R. C. A.; Middlemiss, Bruin Res. 1992, 596, 223-230.
D. N.; Bowen, D. M.
27.
Foster, A. C.; Kemp, J. A.; Leeson, P. D.; Grimwood, Smith, J. D.; Carling, R. W. Mol. Phurmucol. 1992,41,
28.
Grimwood, 41.923-930.
S.; Moseby,
Yoneda, Y.; Suzuki, T.; Ogita, K.; Han, D. 1. Neumchem. P. P. Mager, Drug Des. Disc. 1994,11, Stauch Slusher, B.; Rhsolo, 97, 175-185. 185-196.
Grn.
Sm.
1994,
32.
Grimwood, 122,969SSm.
S.; Le Bourdelles,
33.
Ferranti, A.; Garuti, L.; Giovanninetti, 42, 237-249; Chum_ Abstr. 1987,107,
G.; Gag@, R.; Roncada, P.; Nardi. P. Frrrmrrco, Ed. Sci. 1987, 17237h. G.; De Burlet, G.; Dietz, M. U.S. Patent US 4,952,573, 1990;
34.
L&xc,
Chem. Abstr. 1991, 114, 619Sod. 35. Uchida, M.; Chihiro, M.; Morita, S.; Kanbe, T.; Yamashita, H.; Yamasaki, K.; Yahuuchi, Y.;
Nakagawa, K. Chem. Phurm. BUM 1989, 37, 2109-2116. 36. Gracheva, I. N.; Gridneva, L. I.; Tochilkin. A. I.; Gorkin, V. Z. Khim.-Furm. Chem. Abstr. 1989, 110, 165944~. 31. Miller, K. E.; Huang, C.-T.; Portlock, D. E.; Wright, G. C. fife Sci. 1987,40,63-70. Zh. 1988, 22, 13361339;
15062
A. R.
KATIUTZKY
et al.
38.
Stevens, R. W.; Ikeda, T.; Wakahayashi, H.; Nakane, M. U.S. 1994,121, 57344m.
39.
Kihara, N.; Tomino, I.; Tan, H.; Ishihara, T. Eur. Pat. EP 289.36.5, 1988; Chum. Abstr. 1989, 111, 234028.
40. 41.
Kojima, E.; Saito, K. Eur. Pat EP 402,859, 1990; Chum. Abstr. 1991, 115. 106017~. Youssefyeh, R. D.; Magnien, E.; Lee, T. D. Y.; Chan, W.-K.; Lin, C. J.; Gulemmo, Jr. R. A.; Johnson, C. A.;
Jr. W. H.; Tan, J.; Campbell, H. F.; Huang, F.-C.; Nuss, G. W; Carnathan, G. W.; Sutherland, Van Inwegen, R. G. J. Med. Chum. 1990,33. 42. Paris, D.; Cottin, M.; Demonchaux, D. J. Med. Chem. 1995, 38, 669-685. 43. 44. Rauckman, B. S.; Tidwell, M. Y.; Johnson, J. V.; Roth, B. J. Md. Ckm_ 1989, 32, 1927-193s. 1186-l 194.
Ogawa, H.; Miydmoto, H.; Kondo, K.; Yamashita, H.; Nakaya, K.; Komatsu, H.; Tanaka, M.; Takara, S.; Tominaga, M.; Yahuchi, Y. Kokai Tokkyo Koho JP, 04,321,66Y, lYY2; Chum. Abstr. 1993, IIY, 249979~.
4.5. 46.
Bigg, D.; Mangane, M. Fr. Pat. FR 2,.576,308, 1986; Chum. Abstr. 1987, 106, 1022x4~. Nagasaka, T.; Kosugi, Y.; Kawahara, T.; Kakimoto, M.; Tamuru, K.; Himta, A. Jpn. Pat. OS, 379,267, 1993; Chrm. Abstr. 1994, 120,244692q.
41.
Moon, M. W.; Morris, J. K.; Heier, R. F.; Chidester, C. G.; Hoffmann, W. E.; Piercey. J. S.; VonVoigtlander, 1092.
M. F.; Althaus,
P. F.; Evans, D. L.; Figur, L. M.; Lahti, R. A. J. Mrrl. Chrm. 1992, 35, 1076-
48. 49.
Buzas, A.; Ollivier, R.; El Ahmad, Y.; Laurent, E. PCT Int. Appl. WO 93 16,057, lYY3; Chrm. Abstr. 1994,120, 13452%.
so.
Agarwal, S. K.; Saxena, A. K.; Jam, P. C.; Sur, R. N.; Srimal, R. C.; Dhawan, B. N.; Anand, N. Indian .J. Chrm., Sect. E 1987,26B, 642-646; Chum. Abstr. 1989, 1 IO, 1147XYj. S.; Yamdshita, H.; Yamasaki, K.; Kunk, T.; Yahuuchi. Y.;
Sl.
Uchida,
M.; Chihiro,
M.; Morita,
1575-1586.
Uchida, M.; Morita, S.; Chihiro, M. Eur. Pat. EP 239,129, 19X7; Chem. Abstr. 1988, 108, 18674Ot. Atwal, K. Eur. Pat. EP 488,6 16, 1992; Chem. Abstr. 1992, 117, XYY7Xc. Santangelo, F.; Casagrande, C.; Miragoli, G.; Vecchietti, V. Em=..I. Mtd. Chrm. 1994,2Y, X77-X82.
Synthesis
of 1,2,3,4-tetrahydroquinolines
15063
Galtier, D.; Lassalle, G. Eur. Pat.. EP 643,046, 199.5; Chrm Abstr. 1995, 122, 265264h. Lassalle, G.; Galtier, D.; Galli, F. Eur. Pat. EP 643,047, 1995; Chrm. Ahstr. 1995, 122, 26.5377x. Baumgarth, M.; Lues, I.; Minck, K.O.; Beier, N. Ger. Pat. DE 4,321,366. 1995; Chrm. Ahstr. 1995,
122, 187620e. 58. 59. Biller, S. A.; Misra, R. N. U.S. Pat. US 4,843,0X2, 19X9; Chrm Ahstr. 1989, 111, 2326oOj. Lukevics, E.; Lapina, T.; Segals, I.; Augustane, 951; Chem. Abstr. 1988, 109, 222016t.
60.
Kohno, Y.; Kojima, E. Eur. Potent EP 403,980 (1990); Chem. Abstr. 1991, 114, 207OShr. Kohno, Y.; Awano, K.; Ishizaki, T.; Kojirna, E.; Kudoh, S.; Sakoe. Y.; Saito, K. PCT Int. Appl. WO 92 18,482, 1992; Chem. Abstr. 1993, 119, 11713Sq.
61.
62.
Kono, Y.; Kojima, E.; Saito, K.; Kudo, S.; Sekoe, Y. Kokai Tokkycl Koho JP 06 .56,78X, 1994; Chew. Abstr. 1994, 121) 157.53611.
63.
Carling, R. W.; Leeson, P. D.; Moseley, A. M.; Smith, J. D.; Saywell, K.; Triclehank, M. D.; Kemp, J. A.; Marshall, G. R.; Foster, A. C.; Grimwood, Abstr. 1993, 119, 911Sz. S. Bioorg. Med. Chrm. Lutr. 1993, 3, 65-70; Chpm.
64.
Sanpwan,
N. K.; Malik, M. S.; Dhindsa, K. S.; Chim. Acrrr Turc. 1985, 13, 129-134; Chrmrx Ahtsr.
1987, 107, 77597k. 65. Stevenson, G. L.; Leeson, P. D.; Rowley, M.; Sandarson, I.; Stanslield, I. Binorg. Med. Chrm. Mt.
1992, 2, 371-374; Chem. Abstr. 1993, 119, 180629u. 66. Regnier, G.; Guillonneau, C.; Lepagnol, J.; Lestage, P. Eur. Pat. EP 427.60.5, 1991; Chrm. Abstr. 1991, 115, 136113q. 67. Boursier-Neyret, lI,llhl-1166. 6X. Ventura, C.; Miller, R.; Wolf, H.-P.; Beier, N.; Jonas. R.; Klockow, M.; Lucs. I.; Hano. 0.; Spurgeon, H. A.; Lakatta, E. G.; Capogrossi, 69. Regnier, G.; Guillonneau, M. C. Cir. Res. 1992. 70, 10X1-1090. J. Eur. Pat. EP 2X6,49.5, 19xX; Chew_ C.; Baune, A.; Klippert, P.; Castagne, 1.; Sauveur, C. J. Pharm. Biomrd. And. 1993,
C.; Lepagnol,
70. 1474772. 71. Walter, H. Eur. Pat. 555,183, 1993; Chem. Abstr. 1994, 12O,S4SSlv.
Chrm. Abstr.
1993, II&
15064
A. R. KATRITZKY al. et
72.
Ohsumi, T.; Mito, N.; Oshio, H.; Itaya, N. Nippon Noyaku Gokkuishi 1988, 13, 71-75; Chum. Abstr. 1988,109, XX070a. Zh. V.; Shikhaliev, Kh. S.; Shpanig, E. B. Izv. Vyssh. Uchubn. Zuvrd, Khim. Khim.
73.
Shmyreva,
Tsushima, K.; Osumi, T.; Matsuo, N.; Itaya, N. Agric. Bin/. Cham. 1989,53,2529-2530. Kurahashi, Y.; Shiokawa, K.; Goto, T.; Kagahu, S.; Kamochi, A.; Moriya, K.; Hayakawa, H. Eur. Pat. EP 198,264, 1986; Chcvn. Abstr. 1987,106,9XllSw.
76.
Luzhkov,
V. B.; Fentsov,
D. V.; Kasaikima, 0. T. Zh. Strukt. Khim. 1988, 2Y, 37-41. Chrm. Abstr.
1989, 111,22774t. 77. 78. Meier, H. R.; Evans, S. Eur. Pat EP 273.868, 1988; Chem Abstr. 1989, Ill), 98.598~. Fentsov, D. V.; Lohanova, T. V.; Kassaikiia, 0. T. Nrftukhchimiya lYy0, 30, 103-10X; Chem_ Abstr.
1990,112,234619s. 79. 80. Evans, S. Eur. Pat. EP 497,735, 1992; Chrm.. Abstr. lYY2, 117, 233X6Xp. Shikhaliev, Kh. S.; Shmyreva, Zh. V.; Gurova, E. M. Izv. V$sh. Uchebn. Zuvrd, Khim. Khim..
Zimakova, E. V.; Mamadaliev, Sh. T.; Ivanov, Yu. A. Uzb. Khim. Zh. 1988. 13-16; Chrm Abstr. 1989, 111, 224601~.
x2.
Moser, P. Ger. Pat. DE 3,540,090, 1986; Chrm. Abstr. 1987, 106, IYYS4t. Himeno, K.; Yoshihara, J. Kokai Tokkyo Koho JP 62 39.663, 19X7; Chrm. Abstr. lY87, 1117. 1169Slt. Zhang, Y.; Hou, Y. Huqong 1193Xhw. Xuebao (Chin. Ed) 1992, 43, 2YX-303; Chrm. Abstr. 1993, 119,
Zhang, Y.; Zhang, R.; Hou, Y. Chin. Pat. 1,04099X, 19YO; Chrm. Abstr. 1991, 114. 104357k. Walter, H. Ger. Pat_ DE 3,X17,565, 1988; Chrm. Abstr. lY8Y,llO, 175142~.
Reichardt, C.; Harms, K.; Kinzel, M.; Schafer, G.; Stein, J.; Wocadlo, S. Livbigs Ann. 1995, 3 17-327. Kuroda, M.; Sugata, Y.; Furusho, N. Ger. Pat. DE 3,930,933, lYY0; Chem. Abstr. lyy0, 113, 123813h. Hanatani, 2911632. Y.; Mizuta, Y.; Nakatani, K. Jpn. Pat. JP 03,144,653, 1991; Chrm. Abstr. 1991, 115,
Synthesis
of 1,2,3,4-tetrahydroquinolines
15065
Mabuchi, M. Kokai Tokkyo Koho JP 62,289,845,1987; Tanaka, H. Kokai Tokkyo Koho JP 63,220,160,
Suda, Y.; Sakamoto, M.; Kikuchi, K.; Shimazaki, S. Kokai Tokkyo Koho JP 63,151,955, Absrr. 1989, 111, 31283.
97. 98.
Eckstein, U. Eur. Pat. EP 330,040, 1989; Chem. Abstr. 1990, 112, 100676~. Yamada, M.; Uda, Y.; Mizuno, K.; Tsunemitsu, Abstr. 1990,112, 28246q. 1987; Chum. Abstr. 1988, 10X. 23340~.
Chrm. Chem.
1989; Chem
99. 100. 101. 102. 103. 104. 105. 106. 107. 10X.
H.; Jabs, G. Ger. Pat. DE 3,612,440, 1987; K.; Suzuki, Y. Jpn. Pat. JP 01 47,.587, 1989; 1987;
Chem.
Oono, S.; Okada, M.; Adachi, K. Jpn. Pat. JPOl 90,442. lY8Y; Chrm. Abstr. 1989, 111, 184oY6a. Kojima, K.; Nakanishi, H.; Hioki, T. Jpn. Pat. 62,231,795, 19X7; Chum. Abstr. 1988, 109, 64433~. Hioki, T.; Tomioka, A. Jpn. Pat. JP Ol,lS7,944, 1989;
Chem.
Lau, P. T. S. Eur. Pat. EP 38.5,271, 1990; Chem. Abstr. 1991. 114, 12207.5~. Moore, W. H. U.S. Pat. US 4,788,121, Yamaoka, 1988;
Chrm
Abstr. 1989,110,
24016Ok. 1994;
Chem.
Abstr. 1994, 121, 180456b. 109. Hlasta, D. J.; Luttinger, 1555-1562. 110. 111. 112. 113. Jones, R. C. F.; Smallridge, M. J.; Chapleo, C. B. J.
Chem. Sot., Ptrkin Trams. I 1990,
D.; Perrone, M. H.; Silbernagel, M. J.: Ward, S. J. .I. Serf. Chem. 1987, 30,
385-391.
Shuman, R. T.; Omstein, P. L.; Paschal, J. W.; Gesellchen, Schaus, J. M.; Huser, D. L.; Titus, R. D. Vecchietti,
Synth.
C<>mmun. 1990,20,
V.; Clarke, G. D.; Colle, R.; Giardima, G.; Petrone. G.; Shacchi, M. J. &cl.
1991,
Kate, T.; Tanaka, Y.; Nakamura, M. J. Med Chum. 1994, 37. 3YS6-3YhX.
15066
A. R. KATRI'IZKY et al.
Alvanipour, A.; Kispert. L. D. J. Mol. Cutal. 1988.48, Murahashi, S.-I.; Imada, Y.; Hirai, Y. Tetrahedron Mt.
Marahashi, S.-I.;. Imada, Y.; Hirai, Y. Bull. Chem. Sot. Jpn. 1989.62, Bouyssou, P.; Le Goff, C.; Chenault, .I. J. Heterncycl. Chrm
DAmbra, T. E.; Estep, K. Cl.; Bell, M. R.; Eissenstat, M. A.; Josef, K. A.; Ward, S. J.; Haycock, D. A.; Baizman, E. R.; Casiano, F. M.; Beglin, N. C.; Chippari, S. M.; &ego, T. J. Med. Chcm. 1992,35, 124- 135. Bull. 1986, 34, 390%3YOY. 15291.533. J. D.; Kullnig, R. K.; Daley, G.
Wee, A. G. H.; Liu, B.; Zhang, L. J. Org. Chrm. 1992. 57,4404-4414. Maeda, M. Chem. Phnrmn Bull. 1990, 38, 2577-2580. Grignon-Duhois, M.; Fialeix, M.; Rezzonico, B. Gun. J. Chrm. 1990,6X, 2153-2158.
Buhnov, Yu. N. Pure & Appl. Chrm. 1994,66,23S-244. Sugiura, M.; Sakurai, Y.; Hamada, Y. Hrtuwycles Ashwood, 3267. 1992, 34, %1-56X. 1991. 34, X261-
V. A.; Cassidy, F.; Evans, J. M.; Gagliardi, S.; Stemp, G. J. MA. Chrm.
131. 132. 133. 134. 13.5. 136. 137. 138. 139. 140. 141.
Migneault, D.; Bernstein, M. A.; Lau,C. K. Gun. J. Chem. 1995. 73. lSO6-1513. Murahashi, Murahashi, S.-I.; Oda, T.; Sugahara, T.; Masui, Y. J. Chrm. Sot., Chem. Commzm. 1987. 1471-1472. S.-I.; Oda, T.; Sugahara, T.; Masui, Y. J. Org. Chum. 1990, SS, 1744-1749.
Chrm_ 1984,21, 643-646.
McCord, T. J.; DuBose, C. E.; Shafer, P. L.; Davis, A. L. J. Hetrroqcl. Meyers, A. I.; Milot, G. J. Org. Chrm. 1993, 58, 6.538-6.540.
Coles, N.; Harris, M. C. J.; Whithy, R. 3.; Blagg, J. Org~~nomrt[l/lics 1994, 23, lYO-199. Harris, M. C. J.; Whitby, R. J.; Blagg, J. Tetruhedmn Lctt. 1994. 35, 2431-2434.
Coles, N.; Whitby, R. J.; Blagg, J. Synlrtt 1990,271-272. Coles, N.; Whitby, R. J.; Blagg, J. Synlett 1992, 143-145. (a) Katritzky, results A. R.; Sengupta, S. J. Chum. Sot., Pcrkin Twns. I 1989, 17- IY; (h) - unpublished
Synthesis
of 1,2,3,4-tetrahydroquinolines
15067
Crahh, T. A.; Soilleux, S. L. Tetrahedron 1986, 42, 5407-5413. Crahb, T. A.; Soilleux, S. L. J. Chem. Snc. Pukin Truns. I 1985. 13X l- 1385. Nuuk SSSR, Srr. Khim. 1989, 191-
Shikhaliev, Kh. S.; Kasaikina, 0. T.; Shmyreva, Zh. V. Izv. A/d. 192.
Donnelly, J. A.; Farrell, D. F. J. Org. Chem. 1990, 55, 1757-1761. Tokes, A. L.; Litkei, Gy.; Szilagyi, L. Synth. Commun. 1992.22. Tokes, A. L. Synth. Commun. 1989, 19, 20X1-2086. Bombarda, C.; Erba, E.; Gelmi, M. L.; Pocar, D. J. Hrtrrocycl. Larock, R. C.; Berrios-Pena, 58, 4.509-4s 10. Chrm. lYY2, 29, 1577-1581. 2433-2445.
N. G.; Fried, C. A.; Yum, E. K.; Tu, C.; Leong, W. J. Org. Chrm. lYY3,
150.
Kuznetsov, 64-6X.
V. V.; Al&,
A. E.; Prostakov,
N. S. Chum. Htvrrqd.
151.
Kuznetsov, Comp.(Engl.
V. V.; Aliev, A. E.; Palma. A. R.; Varlamov. A. V.; Prostakov, Trcmsl.) 1991, 7Sh-761.
N. S. C/tern. Hetrrocycl.
152. 1.53. 154. 1.55. 156. 157. 1sx. 159. 160. 161. 162. 163. 164. 165. 166. 167.
McComhie.
Jones, H. 0.; White, E. J. J. Chrm. Sot. Truns. 1910, 97, 632-644. Miller, W. V.; Plochl, J. Brrichtr Dtsch. Chum. Ges. 1896, 20, 1462-72. Crahh, T. A.; Canfield, L. M.; Bowen, D. J. Chem. SK, Turner, A. B.; McBain, B. I.; Howie, R. A. 1. Ckm. Prrkin Trams. 1 lYY4, 9-13.
Clerici, A.; Porta, 0. Trtrrrhrdron Lutt. 1990, 31, 2069-2072. Westerwelle, U.; Keuper, R.; Risch, N. J. Org Chrm. lYY5.60, 2263-2266.
Katritzky, A. R.; Rachwal, B.; Rachwal, S. J. Org. Chrm. lYY5.60, 7631-7640. Park, K. H.; Joe, H. S.; Ahn, K. II.; Jun. K. Trtrohrtlron Katritzky, A. R.; Rachwal, S;. Rachwal, B.; Frankenfcld, Let., lYY5, 36, 594%SY46. .I. W. ht. J. Chew. Kinut. 1995, 27, 351-3.57.
Katritzky A. R.; Gordeev, M. F. J. Org. Chrm. 19Y3, 5X, 4049-4053. Katritzky, A. R.; Rachwal, B.; Rachwal, S. .J. Org. Chrm. 1995, 60,2%X-25%. Katritzky, A. R.; Rachwal, B.; Rachwal, S; Ahhoud, K. A. J. Org. Chew. lY96, 61, in press. Katritzky, A. R.; Rachwal, B.; Rachwal, S. J. Org. Chrm. 1995,611, 3YY3-4001. Mellor, J. M.; M&man, G. D.; Riviere, P. Trtruhrdron Lrtt. 1991, 32, 7 103-7106. 1995,51, 6115-6132.
15068
A. R. KATRITZKY et al.
168.
1963, 5Y,
169.
Shone. T.; Matsumura, Y.; Inoue, K.; Ohmizu, H.; Kashimura, S. J. Am. Chum. Sot. 1982, 104, S75357s7.
170. 171. 172. 173. 174. 17s. 176. 177. 17X. 179. 180. 181. 182. 1X3. 1x4. 185. 186. 1x7. 188. 189. 190. 191. 192. 193. 194.
Fuchigami, T.; Ichikawa, S. J. Org. Chem. 1994, .5Y, 607-615. Murahashi, S.-I.; Naota, T.; Miyaguchi, N.; Nakato, T. TrtrrIhnlron Lrtt. 1992, 33,6991-6994. 1986, 24. 33X5-3395.
Kametani, T.; Takeda, H.; Suzuki, Y.; Kasai, H.; Honda, T. H&rocy/rs
Ha, H.-J.; Ahn, Y.-G.; Chon, J.-K. J. Chem. Sot., Prrkin Trrms. I 1995, 2631-2634. Grillat, G. F.; Schaffrath, R. E. J. Org. Chem. 1959. 24, 1035-1038. Beifuss U.; Ledderhose, S. J. Chem SW., Chem. Commun. 1995, 2137-213X. S.; Taraschewski,
Chrm. Grs.
1904,
S.-I.; Naota, T.; Nakato, T. Synlett 1992, X35-X36. S.; Gahe, E.; Lee, F.; Louie, B. J. Org. Chrm.
1988, 53.95 I-9.54.
Murata, S.; Miura, M.; Nomura, M. J. Org. Chrm. 1989, 54. 4700-4702. Dicken, C. M.; Lu, F.-L.; Bruice, T. C. Trtrrihedron Lett. 1986, 27, 5967-5970. Leardini, R.; Nanni, D.; Tundo, A.; Zanardi, G.; Ruggieri F. J. Org. Chrm. 1992, 57. 1X42-1848. Makioka, Y.; Shindo, T.; Taniguchi, Y.; Takaki, K.; Fujiwara, Y. Synthfsi.s 1995, X01-X04. Bortolotti, B.; Leardini, R.; Nanni, D.; Zanardi, G. Trtrrlh&on 1993, 4Y, 10157- 10174.
Kohayashi, S.; Ishitani, H.; Nagayama, S. Chem. Lrtt. 1995, 423-424. Fuchigami, T.; Ichikawa, S.; Kandeel, Z. E.; Konno, A.; Nonaka, T. Heturocyckes 1990. 31, 415-417. Wojciechowski, Wojciechowski, K. Synlett 1991, S71-S72. K. Trtruhedron 1993,49,7277-72X6.
Prrkin Id, Trams. I 19SY. 1354-56.
Foresti, E.; Spagnolo, P.; Zanirato, P. J. Chem. SM., Ito, Y.; Nakajo, E.; Saegusa, T. Synth. Commun. Hino, K.; Nagai, Y.; Uno, H. Chrm Pharm.
Bull.
1073-1()X().
Booth, S. E.; Jenkins, P. R.; Swain, C. J. J. Chrm. Cliffe, W. H.; Dodman, D.; Meth-Cohn,
19Y3, 147-149.
0. J. Chum. SM.
Synthesis of 1,2,3,4-tetrahydroquinolines
15069
Biographical
Sketch
Alan R. Katritzky, born in 1928 in London, U.K., is Kenan Professor Director of the Institute for Heterocyclic hearted overview account of his life appeared Compounds
of Chemistry and
in J. Het. Chem.,
of his scientific
work in Heterocycles,
international
Stanislaw
in 1978 at
JagielIonian University, Krakow, Poland. He was an Assistant Professor University (1980-88). and group leader in the Katritzky
group at the
Florida (1988-93).
Currently
Major topics of his 60 scientific papers include benzotriazole the preparation sterenchemical of amines and ethers, studies based on NMR. various aspects
of heterocyclic
Bogumila Jagiellonian
Rachwal, University,
her MS in chemistry
in 1980 at the
specialist
Pharmos Inc., Alachua, Florida and the proud mother of four children and over SO0 new compounds.
15070
A. R. KATRITZKY
et al.
Alan R. Katritzky
Stanislaw Rachwal
Bogumila Rachwal